EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Artificial Intelligence for the Digital Revolution of Pharmaceutical Manufacturing
Currently Artificial Intelligence AIMachine Learning ML model development programs are scattered and difficult to use particularly for scientists with less experience in computer programming eg Python Different computer programs are needed to deploy different AIML methods
-
Techno Trends
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen an investigational treatment for spinal muscular atrophy SMA
-
Projects
Siemens Invests $14 Million in Drummondville Plant Expansion to Advance Digital Manufacturing
Siemens Canada has completed a major expansion and modernisation project at its manufacturing facility in Drummondville Qubec The yearlong project represents an investment of approximately US million
-
Research Insights
Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro
Iscalimab is a nondepleting antiCD monoclonal antibody expected to suppress immune responses by blocking the costimulation by antigenpresenting cells through CDCDL ligation
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
How to Build a Metrics-Driven Culture in Pharma Quality Management
Kavita Vengurlekar
This article explores how pharma companies can build a metrics-driven quality culture that empowers teams and strengthens regulatory trust. It highlights critical QA metrics, real-world use cases, and...
-
2
Challenges and Opportunities in Market Access for New Drugs
Kate Williamson
Navigating market access for new drugs involves overcoming regulatory hurdles, high development costs, clinical trial challenges, and pricing issues. Opportunities include innovative regulatory pathwa...
-
3
Revolutionizing Clinical Research: The Role of Energy-Efficient Trial Sites
Harry Callum
Eco-friendly trial sites are revolutionizing clinical research through their low energy use, low environmental footprint, and increased operating performance. These facilities reduce costs, enhance re...
-
4
Embracing AI to Revolutionize Drug Safety: A Call for Modernizing Pharmacovigilance Practices
Pramod Kumar
Pharmacovigilance is vital for protecting patients, but traditional approaches fail to address diverse populations and real-world complexities. This article highlights how AI, particularly LLMs and Ge...
-
5
Advertise with Pharma Focus America – Reach America’s Most Influential Pharma Decision Makers
Kate Williamson
The current pharmaceutical and biopharmaceutical environment is very competitive and therefore the ability to cut across the right audience is no longer an option but a strategy. Marketing budgets nee...
press releasesRead more...
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
Amneal Pharmaceuticals Inc today announced that it has received US Food and Drug Administration FDA approval for additional strengths and vial presentations of iohexol injection mg iodinemL in mL
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
Eli Lilly and Company and AtaiBeckley Inc a clinicalstage biopharmaceutical company developing innovative therapeutics for mental health conditions today announced a definitive agreement for Lilly to acquire AtaiBeckley
Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors
Moderna Inc today announced the dosing of the first US participant in its Phase study evaluating mRNA a tumortargeted cancer antigen therapy candidate in patients with advanced or metastatic solid tumors
Galmed Announces the Breakthrough Development of Novel LNP Cardiac Targeted Formulation of its SCD1 inhibitor, Aramchol
Galmed Pharmaceuticals Ltd NASDAQ GLMD Galmed or the Company a clinicalstage biopharmaceutical company focused on liver cardiometabolic and GI oncology diseases today announced the breakthrough development
Events Read more...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
26 - 30
Jul 2026ADLM 2026
Anaheim, CA USA
27 - 28
Jul 2026Pharmacovigilance & Drug Safety 2026
Rome, Italy
27 - 28
Jul 2026Pharmacology 2026
Rome, Italy
27 - 28
Jul 2026PharmaSci Innovations 2026
Rome, Italy
LATEST NEWSRead more...
FDA grants traditional approval to Novartis' Fabhalta for primary IgA nephropathy
Novartis has announced that the US Food and Drug Administration FDA has granted traditional approval to Fabhalta iptacopan for slowing kidney function decline in adults with primary immunoglobulin A nephropathy
Illumina Expands Billion Cell Atlas Programme with New AI Drug Development Partners
Illumina has expanded its Billion Cell Atlas programme by adding three new member companies including AInative drug developer Formation Bio to support the development of nextgeneration therapies
Jasper Therapeutics Completes Merger with Kira Pharmaceuticals
Jasper Therapeutics has completed its acquisition of Kira Pharmaceuticals in an allstock transaction creating a combined company focused on developing treatments for immunemediated diseases
AstraZeneca Secures Global Licence for EGFR Inhibitor Zegfrovy from Dizal Pharmaceutical
AstraZeneca has entered into an exclusive global licensing agreement with Dizal Pharmaceutical for Zegfrovy sunvozertinib an oral irreversible epidermal growth factor receptor EGFR inhibitor
ORIC Pharmaceuticals Begins Phase 3 Himalayas-1 Trial for Advanced Prostate Cancer
ORIC Pharmaceuticals has initiated the global Himalayas Phase registrational trial to evaluate rinzimetostat in combination with NUBEQA darolutamide for patients with metastatic castrationresistant prostate cancer
Biogen Reports Positive Phase 2 Results for Diranersen in Early Alzheimer’s Disease
Biogen has presented detailed Phase CELIA study results for its investigational antisense oligonucleotide ASO therapy diranersen at the Alzheimers Association International Conference AAIC
